From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers

References

• Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K. & Hodges, J.R. (2007). Focal cortical presentations of Alzheimer's disease. Brain, 130, 2636–2645.
   PubMed Web of Science ®Google Scholar
• Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., … Gao, F. (2012). Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Reports, 2, 789–798.
   PubMed Web of Science ®Google Scholar
• Alzheimer, A. (1911). Uber eigenartige Krankheitsfaelle des spaeteren Alters [About strange diseases of older age]. Zeitschrift fuer die gesamte Neurologie und Psychiatrie [Magazine for Neurology and Psychiatry], 4, 356–386.
   Google Scholar
• Alzheimer Disease & FTD Mutation Database (2012). http://www.molgen.ua.ac.be/ftdmutations
   Google Scholar
• Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., … Oda, T. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications, 351, 602–611.
   PubMed Web of Science ®Google Scholar
• Baker, M., Mackenzie, I. R., Pickering-Brown, S.M., Gass, J., Rademakers, R., Lindholm, C., … Hutton, M. (2006). Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature, 442, 916–919.
   PubMed Web of Science ®Google Scholar
• Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., Fox, N.C., … Morris, J. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367, 795–804.
   PubMed Web of Science ®Google Scholar
• Bian, H., Van Swieten, J.C., Leight, S., Massimo, L., Wood, E., Forman, M., … Grossman, M. (2008). CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology, 70, 1827–1835.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology andl Therapeutics, 69(3), 89–95.
   PubMed Web of Science ®Google Scholar
• Boeve, B.F., Maraganore, D.M., Parisi, J.E., Ahlskog, J.E., Graff-Radford, N., Caselli, R.J., … Peterson, R. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53, 795–800.
   PubMed Web of Science ®Google Scholar
• Borroni, B., Alberici, A., Grassi, M., Turla, M., Zanetti, O., Bianchetti, A., … Padovani, A. (2010). Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy. Journal of Alzheimer's Disease, 19, 111–116.
   PubMed Web of Science ®Google Scholar
• Borroni, B., Malinverno, M., Gardoni, F., Alberici, A., Parnetti, L., Premi, E., … Padovani, A. (2008). Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology, 71, 1796–1803.
   PubMed Web of Science ®Google Scholar
• Cairns, N.J., Neumann, M., Bigio, E.H., Holm, I.E., Troost, D., Hatanpaa, K.J., … Mackenzie, I. (2007). TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. American Journal of Pathology, 171, 227–240.
   PubMed Web of Science ®Google Scholar
• Choi, S.R., Golding, G., Zhuang, Z., Zhang, W., Lim, N., Hefti, F., … Kung, H. (2009). Preclinical properties of 18F-AV-45: A PET agent for Abeta plaques in the brain. Journal of Nuclear Medicine, 50, 1887–1894.
   PubMed Web of Science ®Google Scholar
• Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., … Van Broeckhoven, C. (2006). Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 442, 920–924.
   PubMed Web of Science ®Google Scholar
• Davidsson, P., Sjogren, M., Andreasen, N., Lindbjer, M., Nilsson, C.L., Westman-Brinkmalm, A. & Blennow, K. (2002a). Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Molecular Brain Research, 109, 128–133.
   PubMedGoogle Scholar
• Davidsson, P., Westman-Brinkmalm, A., Nilsson, C.L., Lindbjer, M., Paulson, L., Andreasen, N., … Blennow, K. (2002b). Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport, 13, 611–615.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., … Rademakers, R. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72, 245–256.
   PubMed Web of Science ®Google Scholar
• Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., … Eggan, K. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218–1221.
   PubMed Web of Science ®Google Scholar
• Finch, N., Baker, M., Crook, R., Swanson, K., Kuntz, K., Surtees, R., … Rademakers, R. (2009). Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain, 132, 583–591.
   PubMed Web of Science ®Google Scholar
• Forman, M.S., Farmer, J., Johnson, J.K., Clark, C.M., Arnold, S.E., Coslett, H.B., … Grossman, M. (2006). Frontotemporal dementia: Clinicopathological correlations. Annals of Neurology, 59, 952–962.
   PubMed Web of Science ®Google Scholar
• Foster, N.L., Heidebrink, J.L., Clark, C.M., Jagust, W.J., Arnold, S.E., Barbas, N.R., … Minoshima, S. (2007). FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain, 130, 2616–2635.
   PubMed Web of Science ®Google Scholar
• Foulds, P., McAuley, E., Gibbons, L., Davidson, Y., Pickering-Brown, S.M., Neary, D., … Mann, D. (2008). TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathologica, 116, 141–146.
   PubMed Web of Science ®Google Scholar
• Gordon, E., Rohrer, J.D., Kim, L.G., Omar, R., Rossor, M.N., Fox, N.C. & Warren, J.D. (2010). Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study. Neurology, 74, 666–673.
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini, M.L., Brambati, S.M., Ginex, V., Ogar, J., Dronkers, N.F., Marcone, A., … Miller, B. (2008). The logopenic/phonological variant of primary progressive aphasia. Neurology, 71, 1227–1234.
   PubMed Web of Science ®Google Scholar
• Grossman, M. (2010). Primary progressive aphasia: Clinicopathological correlations. Nature Reviews in Neurology, 6, 88–97.
   PubMed Web of Science ®Google Scholar
• Grossman, M., Xie, S.X., Libon, D.J., Wang, X., Massimo, L., Moore, P., … Trojanowski, J. (2008). Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology, 70, 2036–2045.
   PubMed Web of Science ®Google Scholar
• Harvey, R.J., Skelton-Robinson, M. & Rossor, M.N. (2003). The prevalence and causes of dementia in people under the age of 65 years. Journal of Neurology, Neurosurgery and Psychiatry, 74, 1206–1209.
   PubMed Web of Science ®Google Scholar
• Hodges, J.R., Davies, R.R., Xuereb, J.H., Casey, B., Broe, M., Bak, T.H., … Halliday, G. (2004). Clinicopathological correlates in frontotemporal dementia. Annals of Neurology, 56, 399–406.
   PubMed Web of Science ®Google Scholar
• Hsiung, G.Y., Fok, A., Feldman, H.H., Rademakers, R. & Mackenzie, I.R. (2011). rs5848 polymorphism and serum progranulin level. Journal of the Neurological Sciences, 300, 28–32.
   PubMed Web of Science ®Google Scholar
• Hu, W.T., Chen-Plotkin, A., Arnold, S.E., Grossman, M., Clark, C.M., Shaw, L.M., … Trojanowski, J. (2010a). Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathologica, 120, 385–399.
   PubMed Web of Science ®Google Scholar
• Hu, W.T., Chen-Plotkin, A., Grossman, M., Arnold, S.E., Clark, C.M., Shaw, L.M., … Trojanowski, J. (2010b). Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology, 75, 2079–2086.
   PubMed Web of Science ®Google Scholar
• Hutchinson, A.D. & Mathias, J.L. (2007). Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: A meta-analytic review. Journal of Neurology, Neurosurgery and Psychiatry, 78, 917–928.
   PubMed Web of Science ®Google Scholar
• Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., … Heutink, P. (1998). Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702–705.
   PubMed Web of Science ®Google Scholar
• Irwin, D.J., McMillan, C.T., Toledo, J.B., Arnold, S.E., Shaw, L.M., Wang, L.S., … Grossman, M. (2012). Comparison of cerebrospinal fluid levels of tau and Abeta 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Archives of Neurology, 69(8), 1018–1025.
   PubMedGoogle Scholar
• Ishii, K., Sakamoto, S., Sasaki, M., Kitagaki, H., Yamaji, S., Hashimoto, M., … Mori, E. (1998). Cerebral glucose metabolism in patients with frontotemporal dementia. Journal of Nuclear Medicine, 39, 1875–1878.
   PubMed Web of Science ®Google Scholar
• Israel, M.A., Yuan, S.H., Bardy, C., Reyna, S.M., Mu, Y., Herrera, C., … Goldstein, L. (2012). Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature, 482, 216–220.
   PubMed Web of Science ®Google Scholar
• Jack, C.R., Jr, Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., … Trojanowski, J. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9, 119–128.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A. & Dickson, D.W. (2003). Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Movement Disorders, 18, 1018–1026.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Hodges, J.R., Snowden, J.S., Mackenzie, I.R., Neumann, M., Mann, D.M. & Dickson, D.W. (2011). Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathologica, 122, 137–153.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Petersen, R.C., Knopman, D.S., Boeve, B.F., Whitwell, J.L., Duffy, J.R., … Dickson, D. (2006). Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology, 66, 41–48.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Tang-Wai, D.F., Edland, S.D., Knopman, D.S., Dickson, D.W., Parisi, J.E., … Boeve, B. (2004). Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Archives of Neurology, 61, 1881–1884.
   PubMedGoogle Scholar
• Josephs, K.A., Whitwell, J.L., Dickson, D.W., Boeve, B.F., Knopman, D.S., Petersen, R.C., … Jack, C. (2008). Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiology of Aging, 29, 280–289.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Whitwell, J.L., Parisi, J.E., Petersen, R.C., Boeve, B.F., Jack, C.R., Jr & Dickson, D.W. (2010). Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. European Journal of Neurology, 17, 969–975.
   PubMed Web of Science ®Google Scholar
• Kasai, T., Tokuda, T., Ishigami, N., Sasayama, H., Foulds, P., Mitchell, D.J., … Nakagawa, M. (2009). Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathologica, 117, 55–62.
   PubMed Web of Science ®Google Scholar
• Kertesz, A., McMonagle, P., Blair, M., Davidson, W. & Munoz, D.G. (2005). The evolution and pathology of frontotemporal dementia. Brain, 128, 1996–2005.
   PubMed Web of Science ®Google Scholar
• Kim, E.J., Rabinovici, G.D., Seeley, W.W., Halabi, C., Shu, H., Weiner, M.W., … Rosen, H. (2007). Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery and Psychiatry, 78, 1375–1378.
   PubMed Web of Science ®Google Scholar
• Knopman, D.S., Jack, C.R., Jr, Kramer, J.H., Boeve, B.F., Caselli, R.J., Graff-Radford, N.R., … Mercaldo, N. (2009). Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology, 72, 1843–1849.
   PubMed Web of Science ®Google Scholar
• Knopman, D.S., Kramer, J.H., Boeve, B.F., Caselli, R.J., Graff-Radford, N.R., Mendez, M.F., … Mercaldo, N. (2008). Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain, 131, 2957–2968.
   PubMed Web of Science ®Google Scholar
• Knopman, D.S., Petersen, R.C., Edland, S.D., Cha, R.H. & Rocca, W.A. (2004). The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology, 62, 506–508.
   PubMed Web of Science ®Google Scholar
• Kovacs, G.G., Murrell, J.R., Horvath, S., Haraszti, L., Majtenyi, K., Molnar, M.J., … Spina, S. (2009). TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Movement Disorders, 24, 1843–1847.
   PubMed Web of Science ®Google Scholar
• Kuhle, J., Lindberg, R.L., Regeniter, A., Mehling, M., Steck, A.J., Kappos, L. & Czaplinski, A. (2009). Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European Journal of Neurology, 16, 771–774.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski, T.J., Jr, Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., … Brown, R. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323, 1205–1208.
   PubMed Web of Science ®Google Scholar
• Libon, D.J., Xie, S.X., Moore, P., Farmer, J., Antani, S., McCawley, G., … Grossman, M. (2007). Patterns of neuropsychological impairment in frontotemporal dementia. Neurology, 68, 369–375.
   PubMed Web of Science ®Google Scholar
• Lindquist, S.G., Holm, I.E., Schwartz, M., Law, I., Stokholm, J., Batbayli, M., … Nielsen, J. (2008). Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. European Journal of Neurology, 15, 377–385.
   PubMed Web of Science ®Google Scholar
• Ling, H., O’Sullivan, S.S., Holton, J.L., Revesz, T., Massey, L.A., Williams, D.R., … Lees, A. (2010). Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain, 133, 2045–2057.
   PubMed Web of Science ®Google Scholar
• Litvan, I., Agid, Y., Jankovic, J., Goetz, C., Brandel, J.P., Lai, E.C., … Pearce, R. (1996). Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology, 46, 922–930.
   PubMed Web of Science ®Google Scholar
• Mackenzie, I.R., Neumann, M., Baborie, A., Sampathu, D.M., Du Plessis, D., Jaros, E., … Lee, V. (2011). A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica, 122, 111–113.
   PubMed Web of Science ®Google Scholar
• Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P. & Kivipelto, M. (2010). Alzheimer's disease: Clinical trials and drug development. Lancet Neurology, 9, 702–716.
   PubMed Web of Science ®Google Scholar
• Mattsson, N., Blennow, K. & Zetterberg, H. (2010). Inter- laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: United we stand, divided we fall. Clincal Chemistry and Laboratory Medicine, 48, 603–607.
   PubMed Web of Science ®Google Scholar
• Mercy, L., Hodges, J.R., Dawson, K., Barker, R.A. & Brayne, C. (2008). Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology, 71, 1496–1499.
   PubMed Web of Science ®Google Scholar
• Mesulam, M., Wicklund, A., Johnson, N., Rogalski, E., Leger, G.C., Rademaker, A., … Bigio, E. (2008). Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Annals of Neurology, 63, 709–719.
   PubMed Web of Science ®Google Scholar
• Mitchell, R.M., Freeman, W.M., Randazzo, W.T., Stephens, H.E., Beard, J.L., Simmons, Z. & Connor, J.R. (2009). A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology, 72, 14–19.
   PubMed Web of Science ®Google Scholar
• Mormino, E.C., Kluth, J.T., Madison, C.M., Rabinovici, G.D., Baker, S.L., Miller, B.L., … Jagust, W. (2009). Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain, 132, 1310–1323.
   PubMed Web of Science ®Google Scholar
• Mukherjee, O., Pastor, P., Cairns, N.J., Chakraverty, S., Kauwe, J.S., Shears, S., … Goate, A. (2006). HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Annals of Neurology, 60, 314–322.
   PubMed Web of Science ®Google Scholar
• Munoz, D.G., Neumann, M., Kusaka, H., Yokota, O., Ishihara, K., Terada, S., … Mackenzie, I. (2009). FUS pathology in basophilic inclusion body disease. Acta Neuropathologica, 118, 617–627.
   PubMed Web of Science ®Google Scholar
• Neumann, M., Mackenzie, I.R., Cairns, N.J., Boyer, P.J., Markesbery, W.R., Smith, C.D., … Lee, V. (2007). TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. Journal of Neuropathology Experimental Neurology, 66, 152–157.
   PubMed Web of Science ®Google Scholar
• Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H.A. & Mackenzie, I.R. (2009a). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain, 132, 2922–2931.
   PubMed Web of Science ®Google Scholar
• Neumann, M., Roeber, S., Kretzschmar, H.A., Rademakers, R., Baker, M. & Mackenzie, I.R. (2009b). Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathologica, 118, 605–616.
   PubMed Web of Science ®Google Scholar
• Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., … Lee, V. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130–133.
   PubMed Web of Science ®Google Scholar
• Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., … Daley, G. (2008). Disease-specific induced pluripotent stem cells. Cell, 134, 877–886.
   PubMed Web of Science ®Google Scholar
• Pasinetti, G.M., Ungar, L.H., Lange, D.J., Yemul, S., Deng, H., Yuan, X., … Ho, L. (2006). Identification of potential CSF biomarkers in ALS. Neurology, 66, 1218–1222.
   PubMed Web of Science ®Google Scholar
• Pick, A. (1892). Über die Beziehungen der senilen Hirnatrophie zur Aphasie [On the relation of senile brain atrophy for aphasia]. Prager medicinische Wochenschrift Prague [Prague Medicine Weekly], 17, 165–167.
   Google Scholar
• Pollock, N.J., Mirra, S.S., Binder, L.I., Hansen, L.A. & Wood, J.G. (1986). Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet, 2, 1211.
   PubMed Web of Science ®Google Scholar
• Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., … Schellenberg, G. (1998). Tau is a candidate gene for chromosome 17 frontotemporal dementia. Annals of Neurology, 43, 815–825.
   PubMed Web of Science ®Google Scholar
• Rabinovici, G.D., Furst, A.J., O’Neil, J.P., Racine, C.A., Mormino, E.C., Baker, S.L., … Jagust, W. (2007). 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology, 68, 1205–1212.
   PubMed Web of Science ®Google Scholar
• Rademakers, R., Eriksen, J.L., Baker, M., Robinson, T., Ahmed, Z., Lincoln, S.J., … Dickson, D. (2008). Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP-43-positive frontotemporal dementia. Human Molecular Genetics, 17, 3631–3642.
   PubMed Web of Science ®Google Scholar
• Rascovsky, K., Salmon, D.P., Hansen, L.A., Thal, L.J. & Galasko, D. (2007). Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology, 21, 20–30.
   PubMed Web of Science ®Google Scholar
• Ratnavalli, E., Brayne, C., Dawson, K. & Hodges, J.R. (2002). The prevalence of frontotemporal dementia. Neurology, 58, 1615–1621.
   PubMed Web of Science ®Google Scholar
• Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., … Traynor, B. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72, 257–268.
   PubMed Web of Science ®Google Scholar
• Rohrer, J.D. & Warren, J.D. (2011). Phenotypic signatures of genetic frontotemporal dementia. Current Opinion in Neurology, 24, 542–549.
   PubMed Web of Science ®Google Scholar
• Rohrer, J.D., Lashley, T., Holton, J., Revesz, T., Urwin, H., Isaacs, A.M., … Warren, J. (2011a). The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery and Psychiatry, 82, 1405–1407.
   PubMed Web of Science ®Google Scholar
• Rohrer, J.D., Lashley, T., Schott, J.M., Warren, J.E., Mead, S., Isaacs, A.M., … Warren, J. (2011b). Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain, 134, 2565–2581.
   PubMed Web of Science ®Google Scholar
• Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association & the National Institute on Aging Working Group (1998). Consensus report of the Working Group on: ‘Molecular and Biochemical Markers of Alzheimer's Disease’. Neurobiology of Aging, 19(3), 109–116.
   PubMed Web of Science ®Google Scholar
• Rosen, H.J., Gorno-Tempini, M.L., Goldman, W.P., Perry, R.J., Schuff, N., Weiner, M., … Miller, B. (2002). Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology, 58, 198–208.
   PubMed Web of Science ®Google Scholar
• Rosen, H.J., Narvaez, J.M., Hallam, B., Kramer, J.H., Wyss-Coray, C., Gearhart, R., … Miller, B. (2004). Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia. Alzheimer's Disease and Associated Disorders, 18, 202–207.
   PubMed Web of Science ®Google Scholar
• Ruetschi, U., Zetterberg, H., Podust, V.N., Gottfries, J., Li, S., Hviid Simonsen, A., … Blennow, K. (2005). Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Experimental Neurology, 196, 273–281.
   PubMed Web of Science ®Google Scholar
• Seelaar, H., Klijnsma, K.Y., de Koning, I., van der Lugt, A., Chiu, W.Z., Azmani, A., … van Swieten, J. (2010). Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. Journal of Neurology, 257, 747–753.
   PubMed Web of Science ®Google Scholar
• Shaw, L.M., Vanderstichele, H., Knapik-Czajka, M., Figurski, M., Coart, E., Blennow, K., … Trojanowski, J. (2011). Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathologica, 121, 597–609.
   PubMed Web of Science ®Google Scholar
• Shi, Y., Kirwan, P., Smith, J., MacLean, G., Orkin, S.H. & Livesey, F.J. (2012). A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Science Translational Medicine, 4(124), 124ra129.
   Web of Science ®Google Scholar
• Skibinski, G., Parkinson, N.J., Brown, J.M., Chakrabarti, L., Lloyd, S.L., Hummerich, H., … Collinge, J. (2005). Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nature Genetics, 37, 806–808.
   PubMed Web of Science ®Google Scholar
• Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. & Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences USA, 95, 7737–7741.
   PubMed Web of Science ®Google Scholar
• Steinacker, P., Hendrich, C., Sperfeld, A.D., Jesse, S., von Arnim, C.A., Lehnert, S., … Otto, M. (2008). TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Archives of Neurology, 65, 1481–1487.
   PubMed Web of Science ®Google Scholar
• Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nature Protocols, 2, 3081–3089.
   PubMed Web of Science ®Google Scholar
• Trojanowski, J.Q., Arnold, S.E., Karlawish, J.H., Brunden, K., Cary, M., Davatzikos, C., … Lee, V. (2010). Design of comprehensive Alzheimer's disease centers to address unmet national needs. Alzheimers Dementia, 6, 150–155.
   PubMed Web of Science ®Google Scholar
• Van Deerlin, V.M., Leverenz, J.B., Bekris, L.M., Bird, T.D., Yuan, W., Elman, L.B., … Yu, C. (2008). TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurology, 7, 409–416.
   PubMed Web of Science ®Google Scholar
• Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., … Shaw, C. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323, 1208–1211.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Klunk, W.E., Huang, G.F., Debnath, M.L., Holt, D.P. & Mathis, C.A. (2002). Synthesis and evaluation of 2-(3’-iodo-4’-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease. Journal of Molecular Neuroscience, 19, 11–16.
   PubMed Web of Science ®Google Scholar
• Watts, G.D., Wymer, J., Kovach, M.J., Mehta, S.G., Mumm, S., Darvish, D., … Kimonis, V. (2004). Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nature Genetics, 36, 377–381.
   PubMed Web of Science ®Google Scholar
• Whitwell, J.L., Jack, C.R., Jr, Parisi, J.E., Knopman, D.S., Boeve, B.F., Petersen, R.C., … Josephs, K. (2007). Rates of cerebral atrophy differ in different degenerative pathologies. Brain, 130, 1148–1158.
   PubMedGoogle Scholar
• Whitwell, J.L., Warren, J.D., Josephs, K.A., Godbolt, A.K., Revesz, T., Fox, N.C. & Rossor, M.N. (2004). Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegenerative Disorders, 1, 225–230.
   PubMed Web of Science ®Google Scholar
• Wong, D.F., Rosenberg, P.B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H.T., … Pontecorvo, M. (2010). In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). Journal of Nuclear Medicine, 51, 913–920.
   PubMed Web of Science ®Google Scholar
• Yamada, T., Moroo, I., Koguchi, Y., Asahina, M. & Hirayama, K. (1994). Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy. Acta Neurologica Scandanavica, 89, 42–46.
   PubMed Web of Science ®Google Scholar
• Yasui, K., Inoue, Y., Kanbayashi, T., Nomura, T., Kusumi, M. & Nakashima, K. (2006). CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. Journal of Neurological Sciences, 250, 120–123.
   PubMed Web of Science ®Google Scholar
• Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., … Thomson, J. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
   PubMed Web of Science ®Google Scholar
• Zamboni, G., Huey, E.D., Krueger, F., Nichelli, P.F. & Grafman, J. (2008). Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology, 71, 736–742.
   PubMed Web of Science ®Google Scholar
• Zetterberg, H., Jacobsson, J., Rosengren, L., Blennow, K. & Andersen, P.M. (2007). Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: Impact of SOD1 genotype. European Journal of Neurology, 14, 1329–1333.
   PubMed Web of Science ®Google Scholar
• Zhou, J., Greicius, M.D., Gennatas, E.D., Growdon, M.E., Jang, J.Y., Rabinovici, G.D., … Seeley, W. (2010). Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain, 133, 1352–1367.
   PubMed Web of Science ®Google Scholar